Intrexon Corporation (XON) was a big mover last session with shares rising nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost over 17% in the past one-month time frame.
This biotechnology company has seen one negative estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved lower over the same period. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can last.
Intrexon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Better-ranked Med-Drug stocks worth considering include ICON plc (ICLR), Omnicare Inc. (OCR) and Quintiles Transnational Holdings Inc. (Q). While ICLR sports a Zacks Rank #1 (Strong Buy), OCR and Q carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
INTREXON CORP (XON): Free Stock Analysis Report
ICON PLC ORD (ICLR): Free Stock Analysis Report
OMNICARE INC (OCR): Free Stock Analysis Report
QUINTILES TRANSNATIONAL HOLDINGS (Q): Free Stock Analysis Report
Zacks Investment Research